Rxsight Stock Investor Sentiment
| RXST Stock | USD 46.06 0.32 0.69% |
Slightly above 68% of Rxsight's investor base is looking to short. The analysis of overall sentiment of trading Rxsight stock suggests that many investors are alarmed at this time. Rxsight's investing sentiment can be driven by a variety of factors including economic data, Rxsight's earnings reports, geopolitical events, and overall market trends.
Rxsight |
Rxsight Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Rxsight can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Rxsight that are available to investors today. That information is available publicly through Rxsight media outlets and privately through word of mouth or via Rxsight internal channels. However, regardless of the origin, that massive amount of Rxsight data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Rxsight news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Rxsight relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Rxsight's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Rxsight alpha.
Rxsight Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 3100 shares by Ilya Goldshleger of Rxsight at 56.111 subject to Rule 16b-3 | 09/17/2024 |
2 | Disposition of 3105 shares by Ilya Goldshleger of Rxsight at 49.2926 subject to Rule 16b-3 | 09/26/2024 |
3 | Insider Selling RxSight, Inc. Insider Sells 151,962.00 in Stock | 10/03/2024 |
4 | Disposition of 206 shares by Ilya Goldshleger of Rxsight at 48.65 subject to Rule 16b-3 | 10/04/2024 |
5 | Disposition of 3105 shares by Ilya Goldshleger of Rxsight at 48.8231 subject to Rule 16b-3 | 10/10/2024 |
6 | Disposition of 3100 shares by Ilya Goldshleger of Rxsight at 50.1915 subject to Rule 16b-3 | 10/11/2024 |
7 | Disposition of 3100 shares by Ilya Goldshleger of Rxsight at 50.0865 subject to Rule 16b-3 | 10/14/2024 |
8 | Disposition of 3100 shares by Ilya Goldshleger of Rxsight at 49.7799 subject to Rule 16b-3 | 10/16/2024 |
9 | Disposition of 3100 shares by Ilya Goldshleger of Rxsight at 49.6778 subject to Rule 16b-3 | 10/22/2024 |
10 | Disposition of 3100 shares by Ilya Goldshleger of Rxsight at 50.643 subject to Rule 16b-3 | 10/28/2024 |
11 | RxSight Inc Shares Up 4.2 percent on Oct 29 | 10/29/2024 |
12 | Disposition of 260 shares by Ilya Goldshleger of Rxsight at 51.7372 subject to Rule 16b-3 | 11/04/2024 |
13 | What To Expect From RxSight Inc Q3 2024 Earnings | 11/06/2024 |
14 | RxSight Non-GAAP EPS of 0.00 beats by 0.07, revenue of 35.3M beats by 0.23M | 11/07/2024 |
15 | RxSight Inc Shares Down 12.3 percent on Nov 8 | 11/08/2024 |
16 | Acquisition by Corley Jesse Anderson of 11111 shares of Rxsight at 45.3676 subject to Rule 16b-3 | 11/12/2024 |
17 | RxSight, Inc. Shares Acquired by Baillie Gifford Co. | 11/13/2024 |
18 | Rxsights co-president Ilya Goldshleger sells 61,356 in stock | 11/15/2024 |
19 | Disposition of tradable shares by Ilya Goldshleger of Rxsight at 45.07 subject to Rule 16b-3 | 11/18/2024 |
20 | Rxsight co-president Ilya Goldshleger sells 363,752 in stock | 11/19/2024 |
21 | RxSight Trading Down 1.7 percent Should You Sell | 11/22/2024 |
Additional Tools for Rxsight Stock Analysis
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.